These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Author: Northrup NC, Gieger TL, Kosarek CE, Saba CF, LeRoy BE, Wall TM, Hume KR, Childress MO, Keys DA.
    Journal: Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829.
    Abstract:
    Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle). The overall response rate to MPP was 34% for a median of 56 days (95% confidence interval 30-238). Seventeen percent of dogs had a complete response for a median duration of 238 days, 17% had a partial response for a median of 56 days and 32% had stable disease for a median of 24 days. Histological grade or cell morphology on cytology was associated with response. Minimal toxicity was observed with the MPP protocol, suggesting that further dose intensification or addition of another chemotherapeutic agent would be possible.
    [Abstract] [Full Text] [Related] [New Search]